CTIS2024-511391-32-00进行中（未招募）1 期
The COlchicine HypERtENsion Trial - COHERENT
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Living address in the Capital Region of Denmark, Age >18 years, Diagnosed with hypertension, Treatment with 1 or more antihypertensive medications, Must fulfill at least one of the following high-risk criteria: a) Diagnosed with type 2 diabetes mellitus OR b) Treatment with lipid-lowering medication for dyslipidemia OR c) Treatment with 2 or more antihypertensive medications, Female patients should either not be of childbearing potential, defined as postmenopausal for at least 1 year or surgically sterile, or is of childbearing potential and practicing one of the following methods of contraception throughout the study and for 30 days after study completion: Hormonal contraception (oral contraceptives, contraceptive implant, injectable birth control, contraceptive patch, or vaginal ring) or intrauterine device, Patients will have given written, informed consent and are able and willing to comply with the requirements of the study protocol
排除标准
- •Colchicine treatment for another cause, e.g. gout, Systemic treatment with moderate or strong cytochrome P450 3A4 (CYP3A4) inhibitors or P-glycoprotein inhibitors (list in Appendix 1), Anemia, thrombocytopenia or leucopenia defined as any of the following measurements within the last 3 months: •Hemoglobin < 7 mmol/L •Platelet count < 110 x 109/L •White blood cell count < 3.0 x 109/L, Female patients who are pregnant, lactating, or considering becoming pregnant during the study or for 6 months after study completion, Significant drug or alcohol abuse during the last year, Current use of or plans to initiate chronic systemic steroid therapy during the study (topical or inhaled steroids are allowed), Chronic inflammatory bowel disease (Crohn’s disease or ulcerative colitis) or chronic diarrhea, Use of other investigational drugs within 30 days of the time of enrollment, Any surgical or medical condition, which in the opinion of the investigator, may place the patient at higher risk from his/her participation in the study, or is likely to prevent the patient from complying with the requirements of the study or completing the study, Allergy/hypersensitivity to colchicine, Known or suspected secondary hypertension, e.g. renal artery stenosis, Uncontrolled hypertension (systolic BP >180 mmHg or diastolic BP >110 mmHg), Known other cardiovascular disease (judged by the investigator), e.g. ischemic heart disease, heart failure, significant valvular disease, arrhythmia, stroke, or peripheral artery disease, History of malignancy of any organ system excluding a successfully treated non-metastatic cutaneous squamous cell or basal cell carcinoma, localized prostate cancer and/or localized carcinoma in situ of the cervix, Cirrhosis, chronic active hepatitis or other severe hepatic disease, Hemodialysis, Estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2
研究者
相似试验
进行中（未招募）
1 期
The effects of colchicine on the structure and function of the heart and blood vessels in patients with high blood pressureMedDRA version: 21.1Level: LLTClassification code 10081425Term: Arterial hypertensionSystem Organ Class: 10047065 - Vascular disordersMedDRA version: 22.0Level: PTClassification code 10081902Term: Arterial stiffnessSystem Organ Class: 10047065 - Vascular disordersHypertensionEUCTR2020-004492-40-DKCardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev and Gentofte Hospital150
进行中（未招募）
2 期
The COlchicine HypERtENsion TrialHypertensionNCT04916522Herlev and Gentofte Hospital150
进行中（未招募）
1 期
COLCOT Studypatients with atherosclerotic coronary artery disease (CAD)MedDRA version: 20.0Level: HLGTClassification code 10011082Term: Coronary artery disordersSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10028596Term: Myocardial infarctionSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: SOCClassification code 10007541Term: Cardiac disordersSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: HLTClassification code 10011085Term: Ischaemic coronary artery disordersSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: LLTClassification code 10028595Term: Myocardial infarctSystem Organ Class: 10007541 - Cardiac disordersEUCTR2014-005172-28-ITMONTREAL HEART INSTITUTE4,500
进行中（未招募）
1 期
Colchicine Cardiovascular Outcomes Trialpatients with atherosclerotic coronary artery disease (CAD)EUCTR2014-005172-28-PTMontreal Heart Institute4,500
进行中（未招募）
1 期
Colchicine Cardiovascular Outcomes Trialpatients with atherosclerotic coronary artery disease (CAD)EUCTR2014-005172-28-ESMontreal Heart Institute4,500